Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Non Operating Income (2020 - 2024)

SOPHiA GENETICS's Non Operating Income history spans 5 years, with the latest figure at -$2.9 million for Q4 2024.

  • On a quarterly basis, Non Operating Income fell 322.51% to -$2.9 million in Q4 2024 year-over-year; TTM through Dec 2024 was -$5.2 million, a 290.84% decrease, with the full-year FY2024 number at -$5.2 million, down 277.57% from a year prior.
  • Non Operating Income hit -$2.9 million in Q4 2024 for SOPHiA GENETICS, down from $3.4 million in the prior quarter.
  • Over the last five years, Non Operating Income for SOPH hit a ceiling of $3.4 million in Q3 2024 and a floor of -$1.0 billion in Q3 2020.
  • Historically, Non Operating Income has averaged -$102.4 million across 5 years, with a median of -$654500.0 in 2022.
  • Biggest five-year swings in Non Operating Income: surged 1247.77% in 2023 and later plummeted 1549.02% in 2024.
  • Tracing SOPH's Non Operating Income over 5 years: stood at -$1.1 million in 2020, then rose by 19.96% to -$890000.0 in 2021, then surged by 196.07% to $855000.0 in 2022, then surged by 51.23% to $1.3 million in 2023, then tumbled by 322.51% to -$2.9 million in 2024.
  • Business Quant data shows Non Operating Income for SOPH at -$2.9 million in Q4 2024, $3.4 million in Q3 2024, and -$701000.0 in Q2 2024.